IMLYGIC
As listed in the register: IMLYGIC 1x10e6 UFP/ml solucion inyectable
1x10e6 UFP/ML · solución inyectable
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Talimogén laherparepvec
- Made by
- Amgen Europe B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Amgen Europe B.V. |
|---|---|
| Active substance | Talimogén laherparepvec |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 1x10e6 UFP/ML |
| Form | solución inyectable |
| Classification | L01XL02 · Cancer treatments and immune-system medicines |
| Route | vía intralesional |
| Marketed | No — authorised but not currently marketed, according to the register |
| Name in the register | IMLYGIC 1x10e6 UFP/ml solucion inyectable |
| Nº Registro | 1151064001 |
Source: CIMA — Centro de Información online de Medicamentos · 2026-09-30 · not reviewed by a clinician
Fuente: Agencia Española de Medicamentos y Productos Sanitarios (AEMPS), CIMA. Reuse terms: Aviso legal AEMPS.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solución inyectable2 products
- 1x10e6 UFP/ML
- 1x10e8 UFP/ML
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.